These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 16335981)

  • 1. Derivatized cellulose combined with MALDI-TOF MS: a new tool for serum protein profiling.
    Feuerstein I; Rainer M; Bernardo K; Stecher G; Huck CW; Kofler K; Pelzer A; Horninger W; Klocker H; Bartsch G; Bonn GK
    J Proteome Res; 2005; 4(6):2320-6. PubMed ID: 16335981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometric identification of serum peptides employing derivatized poly(glycidyl methacrylate/divinyl benzene) particles and mu-HPLC.
    Rainer M; Najam-ul-Haq M; Bakry R; Huck CW; Bonn GK
    J Proteome Res; 2007 Jan; 6(1):382-6. PubMed ID: 17203982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
    Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
    Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification.
    Leung SM; Pitts RL
    Methods Mol Biol; 2008; 441():57-70. PubMed ID: 18370311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-fast mass fingerprinting by high-affinity capture of peptides and proteins on derivatized poly(glycidyl methacrylate/divinylbenzene) for the analysis of serum and cell lysates.
    Rainer M; Muhammad NU; Huck CW; Feuerstein I; Bakry R; Huber LA; Gjerde DT; Zou X; Qian H; Du X; Wei-Gang F; Ke Y; Bonn GK
    Rapid Commun Mass Spectrom; 2006; 20(19):2954-60. PubMed ID: 16953521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.
    Nanni P; Parisi D; Roda G; Casale M; Belluzzi A; Roda E; Mayer L; Roda A
    Rapid Commun Mass Spectrom; 2007; 21(24):4142-8. PubMed ID: 18022963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemically modified diamond-like carbon (DLC) for protein enrichment and profiling by MALDI-MS.
    Najam-ul-Haq M; Rainer M; Huck CW; Ashiq MN; Bonn GK
    Amino Acids; 2012 Aug; 43(2):823-31. PubMed ID: 22080208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivatized mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine.
    Terracciano R; Pasqua L; Casadonte F; Frascà S; Preianò M; Falcone D; Savino R
    Bioconjug Chem; 2009 May; 20(5):913-23. PubMed ID: 19338374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(glycidyl methacrylate/divinylbenzene)-IDA-FeIII in phosphoproteomics.
    Aprilita NH; Huck CW; Bakry R; Feuerstein I; Stecher G; Morandell S; Huang HL; Stasyk T; Huber LA; Bonn GK
    J Proteome Res; 2005; 4(6):2312-9. PubMed ID: 16335980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.
    Calvano CD; Aresta A; Iacovone M; De Benedetto GE; Zambonin CG; Battaglia M; Ditonno P; Rutigliano M; Bettocchi C
    J Pharm Biomed Anal; 2010 Mar; 51(4):907-14. PubMed ID: 19939598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicolumn separation platform for simultaneous depletion and prefractionation prior to 2-DE for facilitating in-depth serum proteomics profiling.
    Jmeian Y; El Rassi Z
    J Proteome Res; 2009 Oct; 8(10):4592-603. PubMed ID: 19670910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the matrix structure and concentration of polymer-immobilized Ni2+-iminodiacetic acid complexes on retention of IgG1.
    Krácalíková K; Tishchenko G; Bleha M
    J Biochem Biophys Methods; 2006 Apr; 67(1):7-25. PubMed ID: 16466797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum protein profiling by miniaturized solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
    Callesen AK; Mohammed S; Bunkenborg J; Kruse TA; Cold S; Mogensen O; Christensen Rd; Vach W; Jørgensen PE; Jensen ON
    Rapid Commun Mass Spectrom; 2005; 19(12):1578-86. PubMed ID: 15915448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new analytical material-enhanced laser desorption ionization (MELDI) based approach for the determination of low-mass serum constituents using fullerene derivatives for selective enrichment.
    Vallant RM; Szabo Z; Trojer L; Najam-ul-Haq M; Rainer M; Huck CW; Bakry R; Bonn GK
    J Proteome Res; 2007 Jan; 6(1):44-53. PubMed ID: 17203947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins.
    Martosella J; Zolotarjova N; Liu H; Nicol G; Boyes BE
    J Proteome Res; 2005; 4(5):1522-37. PubMed ID: 16212403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
    West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis.
    Ménard C; Johann D; Lowenthal M; Muanza T; Sproull M; Ross S; Gulley J; Petricoin E; Coleman CN; Whiteley G; Liotta L; Camphausen K
    Cancer Res; 2006 Feb; 66(3):1844-50. PubMed ID: 16452246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
    Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
    J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.